CD40LG and mantle cell lymphoma: Moreover, treatment with SP600125 upon anti-IgM stimulation also led to a blockade of BCR-induced EGR-1 upregulation in MCL cell lines (HBL-2 and Granta-519) and in primary MCL cells (UPN1) (Figure 2C).